Last Updated:
Name Designation Appointment Date Status
Mukesh Mahendrakumar Doshi

Appointed as Director since October 2009

Director 11-Oct-2009 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Hitesh Doshi Mukeshkumar

Appointed as Director since October 2009

Director 11-Oct-2009 Current
Yogesh Mukeshkumar Doshi

Appointed as Director since October 2009

Director 11-Oct-2009 Current

People Timeline

Explore the timeline of key personnel in General Drug Private Limited's leadership journey.

Loading...
Contact Details
  • Address Hira House,1St Floor,381-383, S.V.P. Road Near Lilavati School, Mumbai Maharashtra, 400004, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact General Drug Private Limited?
You can contact General Drug Private Limited through their registered address at Hira House,1St Floor,381-383, S.V.P. Road Near Lilavati School, Mumbai Maharashtra, 400004, India, or via their website at dbpharma.in. Social media links are also provided where applicable.
Who are the current directors of General Drug Private Limited?
The current directors of General Drug Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MUKESH MAHENDRAKUMAR DOSHI
  • HITESH DOSHI MUKESHKUMAR
  • YOGESH MUKESHKUMAR DOSHI
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available